New Delhi, Oct. 28 -- Cancer patients across India are set to receive financial relief as pharmaceutical companies reduce drug prices after a directive from the National Pharmaceutical Pricing Authority (NPPA), with the revised Maximum Retail Prices (MRP) taking effect on November 9.

According to a Torrent notice, the company has reduced prices in compliance with an order issued by the NPPA on October 17, 2026. The prices of medicines used for the treatment of colorectal cancer, lung cancer, kidney cancer and other cancers have been reduced.

The BevakALP100 mg injection, which has an existing price of Rs 10,500, will now be available at Rs 4,523.00, a 57 per cent fall in prices.

BevakALP 400 mg injection, with an existing price of Rs 4...